6505--Alendronate Tablets

The solicitation requires offerors to develop a detailed subcontracting plan that complies with FAR 52.219‑9, including justification for any goals set below the VA‑suggested or prior‑year levels, specific methods used to identify potential sources (websites, associations, events, etc.), and a clear statement on whether indirect costs are included in the dollar and percentage goals. Offerors must provide separate dollar and percentage goals for each contract period (base and each option year), indicate total projected subcontracting spend (including indirect costs where applicable), and align the plan period with the company’s fiscal year. The plan must also describe internal and external good‑faith efforts to ensure equitable opportunities for small, veteran‑owned, HUBZone, disadvantaged, and women‑owned businesses, and identify a program administrator with comprehensive duties, including timely eSRS reporting and plan submission 30 days before the current plan expires. In addition, all proposed covered drug products/NDCs must be listed on the offeror’s FSS contract or interim agreement with a permanent FCP by the offer due date; non‑compliant offers will be rejected. Contractors must submit quarterly sales reports and remit cost‑recovery fees, reporting sales values to the nearest dollar for each calendar quarter. The acquisition is a small‑business set‑aside (including HUBZone, SDVOSB, WOSB/EDWOSB) under the applicable NAICS size standard, with a 120‑day price‑hold period, required product samples (at no cost to the Government), and compliance with incorporated FAR provisions (e.g., 52.201‑1, 52.204‑7, 52.214‑34/35). Offerors must provide all required representations, contact information, and adhere to the specified delivery, discount, and payment terms.

Notice ID

8b637a03c24e45588fc3c3e48ef0666e

Solicitation Number

36E79725R0069

NAICS Code

325412

Classification Code

6505